Fewer Life Sciences Co. Investor Suits Lodged In 2011
Securities fraud class actions lodged against life sciences companies dropped by more than 40 percent in 2011, fueled by a decline of suits stemming from the global financial crisis, according to...To view the full article, register now.
Already a subscriber? Click here to view full article